Related Experiment Videos
Interaction between alpha 2-adrenergic and NPY receptor pathways in human erythroleukemia cells
1Department of Pharmacology, University of California, San Diego, La Jolla 92093.
Summary
Neuropeptide Y (NPY) and epinephrine share signaling pathways in human erythroleukemia cells. NPY, like epinephrine, redistributes alpha 2-adrenergic receptors, but they do not synergize to affect calcium or pH levels.
Area of Science:
- Neuroscience
- Cellular Biology
- Pharmacology
Background:
- Neuropeptide Y (NPY) acts as a sympathetic nervous system transmitter.
- NPY's actions resemble alpha 2-adrenergic receptor stimulation.
- Both NPY and epinephrine inhibit adenylate cyclase and mobilize intracellular calcium in human erythroleukemia (HEL) cells.
Purpose of the Study:
- To investigate potential interactions between NPY and epinephrine signaling in HEL cells.
- To determine if NPY affects alpha 2-adrenergic receptor binding or function.
- To examine the combined effects of NPY and epinephrine on intracellular calcium and pH.
Main Methods:
- Radioligand binding assays to assess receptor interactions.
- Measurement of intracellular calcium mobilization.
- Intracellular pH monitoring.
Main Results:
- NPY did not alter antagonist or agonist binding to alpha 2-adrenergic receptors.
- NPY and epinephrine did not show synergistic effects on intracellular calcium mobilization.
- Neither NPY nor epinephrine, alone or combined, affected intracellular pH.
- Preincubation with NPY caused redistribution of alpha 2-adrenergic receptors, similar to epinephrine.
Conclusions:
- NPY and epinephrine utilize overlapping signaling pathways in HEL cells.
- NPY influences alpha 2-adrenergic receptor localization but not ligand binding.
- The interaction between NPY and epinephrine is not synergistic regarding calcium or pH regulation.